Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

Global cancer statistics, 2012

2015 • 26,048 citations

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2018 • 9,811 citations

Management of hepatocellular carcinoma: An update

2011 • 7,867 citations

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

2012 • 4,994 citations

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

1988 • 4,727 citations

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

2002 • 3,356 citations

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

2003 • 2,945 citations

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1999 • 2,625 citations

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

2002 • 2,536 citations

Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men

2000 • 1,626 citations

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

2008 • 1,618 citations

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial

2016 • 616 citations

Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

2010 • 608 citations

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

2007 • 582 citations

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

2011 • 544 citations

Treatment of Unresectable Hepatocellular Carcinoma with Use of 90Y Microspheres (TheraSphere): Safety, Tumor Response, and Survival

2005 • 399 citations

Yttrium-90 Microsphere Therapy for Hepatic Malignancy: Devices, Indications, Technical Considerations, and Potential Complications

2005 • 320 citations

Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology-pathology correlation and survival of radiation segmentectomy

2014 • 267 citations

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

2011 • 255 citations

Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection

2013 • 235 citations

Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization

2009 • 227 citations

Radioembolization with Yttrium-90 Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies

2006 • 205 citations

Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma

2009 • 185 citations

Statistical Monitoring of Clinical Trials: a Unified Approach

2007 • 185 citations

Imaging Response in the Primary Index Lesion and Clinical Outcomes Following Transarterial Locoregional Therapy for Hepatocellular Carcinoma

2010 • 184 citations

Chemoembolization for Hepatocellular Carcinoma: Comprehensive Imaging and Survival Analysis in a 172-Patient Cohort

2010 • 151 citations

Statistical Monitoring of Clinical Trials: A Unified Approach

2006 • 144 citations

Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator

2016 • 78 citations

Superselective Yttrium-90 Radioembolization for Hepatocellular Carcinoma Yields High Response Rates with Minimal Toxicity

2014 • 75 citations

Stopping clinical trials early for futility: retrospective analysis of several randomised clinical studies

2012 • 72 citations

Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma

2015 • 56 citations

Same-day 90Y radioembolization: implementing a new treatment paradigm

2016 • 56 citations

The Use of Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma: A Response to the Cochrane Collaboration Review of 2011

2011 • 29 citations

Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma

2011 • 2 citations